These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 7180545)

  • 1. [Study of insoluble contaminants in large-volume parental infusion fluids, II. Evaluation of the degree of contamination with insoluble particles of parenteral infusion fluids produced by the pharmaceutical industry and hospital pharmacies].
    Pawlaczyk J; Nowacka D; Wawrzyńczak D
    Acta Pol Pharm; 1982; 39(1-3):151-7. PubMed ID: 7180545
    [No Abstract]   [Full Text] [Related]  

  • 2. [Insoluble contaminants in large-volume parenteral solutions. III. Effect of drug containers and sterilization].
    Pawlaczyk J; Nowacka D
    Acta Pol Pharm; 1983; 40(2):199-206. PubMed ID: 6659998
    [No Abstract]   [Full Text] [Related]  

  • 3. [Insoluble contaminants in large-volume parenteral infusion fluids. Use of the particle counter LZ-2].
    Pawlaczyk J; Nowacka D
    Acta Pol Pharm; 1981; 38(4):473-8. PubMed ID: 7331835
    [No Abstract]   [Full Text] [Related]  

  • 4. [Microbiological evaluation of intravenous infusion residues].
    Fiebig A; Barteczko I; Halkiewicz A; Stechnij I
    Pol Tyg Lek; 1981 Sep; 36(38):1459-62. PubMed ID: 7329860
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on microbial contamination of infusion fluids arising from drug additions and administration.
    Ernerot L; Thorén S; Sandell E
    Acta Pharm Suec; 1973 May; 10(2):141-6. PubMed ID: 4728099
    [No Abstract]   [Full Text] [Related]  

  • 6. [Possibilities and significance of the production of infusion solutions in hospital pharmacies].
    Frank P
    Infusionstherapie (1973); 1974 Apr; 1(4):319-23. PubMed ID: 4219374
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of a disposable rubber closure or bulk irrigating solutions.
    Newton DW; Rogers AG; Croswell RW; Hendrix L
    Am J Hosp Pharm; 1972 Aug; 29(8):678-83. PubMed ID: 5052414
    [No Abstract]   [Full Text] [Related]  

  • 8. Recommendations to pharmacists for solving problems with large-volume parenterals.
    Am J Hosp Pharm; 1976 Mar; 33(3):231-6. PubMed ID: 816199
    [No Abstract]   [Full Text] [Related]  

  • 9. Stability issues of parenteral chemotherapy drugs.
    de Lemos ML; Hamata L
    J Oncol Pharm Pract; 2007 Mar; 13(1):27-31. PubMed ID: 17621564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ASHP--hospital intravenous admixture program certification.
    Turco S
    Hosp Pharm; 1978 Jun; 13(6):306, 356. PubMed ID: 10307642
    [No Abstract]   [Full Text] [Related]  

  • 11. Quality control guidelines for single unit packaging of parenterals in the hospital pharmacy.
    Patel JA; Curtis EG; Phillips GL
    Am J Hosp Pharm; 1972 Nov; 29(11):947-51. PubMed ID: 4655003
    [No Abstract]   [Full Text] [Related]  

  • 12. Quality control in admixture services.
    Zellmer WA
    Am J Hosp Pharm; 1978 May; 35(5):527-8. PubMed ID: 655175
    [No Abstract]   [Full Text] [Related]  

  • 13. Adequate and sensible quality control.
    Schoulund B
    J Ir Med Assoc; 1968 Oct; ():Suppl 1:21. PubMed ID: 5701294
    [No Abstract]   [Full Text] [Related]  

  • 14. Pyrogens in small-volume parenterals prepared in hospital pharmacy.
    Lacasa C; Vega FA
    J Parenter Sci Technol; 1989; 43(5):246-9. PubMed ID: 2809933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Particulate matter determination in LVPs produced in Dutch hospital pharmacies. Part 2: Overview of the results.
    Boom FA; Van der Veen J; Verbrugge P; Van de Vaart FJ; Paalman AC; Vos T
    PDA J Pharm Sci Technol; 2000; 54(4):343-58. PubMed ID: 10969531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Premixed intravenous admixtures: a positive development for hospital pharmacy.
    Lee HE
    Am J Hosp Pharm; 1983 Jun; 40(6):1043-4. PubMed ID: 6869393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recommended system for surveillance and reporting of problems with large-volume parenterals in hospitals.
    Am J Hosp Pharm; 1975 Dec; 32(12):1251-3. PubMed ID: 1211398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of the Reorganization of Drug Legislation "Act" on the production and admission of infusion solutions].
    Mohrbutter K; Schnieders B; Schuster J; Wolff U
    Klin Anasthesiol Intensivther; 1977; (14):74-88. PubMed ID: 926693
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of two sterility testing methods for intravenous admixtures.
    Condella F; Eichelberger K; Foote LC; Griffin RE
    Hosp Pharm; 1980 Jun; 15(6):305-10. PubMed ID: 10247270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Particulate matter in I.V. infusion fluids.
    Davis NN; Turco S; Sivelly E
    Bull Parenter Drug Assoc; 1970; 24(6):257-70. PubMed ID: 5495399
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.